Annual CFI
-$125.25 M
+$70.10 M+35.88%
31 December 2023
Summary:
IDEXX Laboratories annual cash flow from investing activities is currently -$125.25 million, with the most recent change of +$70.10 million (+35.88%) on 31 December 2023. During the last 3 years, it has fallen by -$15.88 million (-14.52%). IDXX annual CFI is now -190.37% below its all-time high of $138.60 million, reached on 31 December 2018.IDXX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$27.37 M
+$5.54 M+16.83%
30 September 2024
Summary:
IDEXX Laboratories quarterly cash flow from investing activities is currently -$27.37 million, with the most recent change of +$5.54 million (+16.83%) on 30 September 2024. Over the past year, it has increased by +$470.00 thousand (+1.69%). IDXX quarterly CFI is now -110.51% below its all-time high of $260.31 million, reached on 31 March 2018.IDXX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$197.65 M
+$470.00 K+0.24%
30 September 2024
Summary:
IDEXX Laboratories TTM cash flow from investing activities is currently -$197.65 million, with the most recent change of +$470.00 thousand (+0.24%) on 30 September 2024. Over the past year, it has dropped by -$53.61 million (-37.21%). IDXX TTM CFI is now -218.58% below its all-time high of $166.69 million, reached on 30 June 2018.IDXX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Cash From Investing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +35.9% | +1.7% | -37.2% |
3 y3 years | -14.5% | +44.9% | +25.3% |
5 y5 years | -190.4% | +26.7% | -32.2% |
IDXX Cash From Investing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -14.5% | +57.3% | at high | +74.4% | -57.8% | +36.3% |
5 y | 5 years | -190.4% | +57.3% | -74.4% | +84.3% | -134.5% | +36.3% |
alltime | all time | -190.4% | +59.4% | -110.5% | +84.3% | -218.6% | +37.9% |
IDEXX Laboratories Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$27.37 M(-16.8%) | -$197.65 M(-0.2%) |
June 2024 | - | -$32.91 M(-69.2%) | -$198.12 M(+2.8%) |
Mar 2024 | - | -$106.94 M(+251.4%) | -$192.69 M(+53.8%) |
Dec 2023 | -$125.25 M(-35.9%) | -$30.43 M(+9.3%) | -$125.25 M(-13.0%) |
Sept 2023 | - | -$27.84 M(+1.3%) | -$144.05 M(-12.9%) |
June 2023 | - | -$27.47 M(-30.5%) | -$165.41 M(-14.3%) |
Mar 2023 | - | -$39.51 M(-19.7%) | -$193.02 M(-1.2%) |
Dec 2022 | -$195.35 M(-33.3%) | -$49.23 M(+0.1%) | -$195.35 M(+2.7%) |
Sept 2022 | - | -$49.20 M(-10.7%) | -$190.16 M(-0.3%) |
June 2022 | - | -$55.09 M(+31.7%) | -$190.64 M(-38.5%) |
Mar 2022 | - | -$41.84 M(-5.0%) | -$310.22 M(+5.9%) |
Dec 2021 | -$292.97 M(+167.9%) | -$44.04 M(-11.3%) | -$292.97 M(+10.7%) |
Sept 2021 | - | -$49.68 M(-71.6%) | -$264.62 M(+12.9%) |
June 2021 | - | -$174.66 M(+610.4%) | -$234.40 M(+178.1%) |
Mar 2021 | - | -$24.59 M(+56.7%) | -$84.29 M(-22.9%) |
Dec 2020 | -$109.38 M(-46.8%) | -$15.69 M(-19.4%) | -$109.38 M(-42.3%) |
Sept 2020 | - | -$19.46 M(-20.8%) | -$189.60 M(-8.6%) |
June 2020 | - | -$24.56 M(-50.6%) | -$207.46 M(-4.4%) |
Mar 2020 | - | -$49.67 M(-48.2%) | -$216.99 M(+5.6%) |
Dec 2019 | -$205.53 M(-248.3%) | -$95.91 M(+157.0%) | -$205.53 M(+37.5%) |
Sept 2019 | - | -$37.33 M(+9.5%) | -$149.46 M(-10.2%) |
June 2019 | - | -$34.09 M(-10.8%) | -$166.35 M(+4.0%) |
Mar 2019 | - | -$38.21 M(-4.1%) | -$159.92 M(-215.4%) |
Dec 2018 | $138.60 M(-199.9%) | -$39.84 M(-26.5%) | $138.60 M(-10.0%) |
Sept 2018 | - | -$54.22 M(+96.1%) | $153.96 M(-7.6%) |
June 2018 | - | -$27.65 M(-110.6%) | $166.69 M(+10.7%) |
Mar 2018 | - | $260.31 M(-1163.1%) | $150.64 M(-208.6%) |
Dec 2017 | -$138.69 M(+52.8%) | -$24.49 M(-41.0%) | -$138.69 M(+7.9%) |
Sept 2017 | - | -$41.49 M(-5.1%) | -$128.48 M(+16.9%) |
June 2017 | - | -$43.70 M(+50.6%) | -$109.94 M(+14.5%) |
Mar 2017 | - | -$29.01 M(+103.2%) | -$96.00 M(+5.7%) |
Dec 2016 | -$90.79 M(-70.6%) | -$14.28 M(-37.8%) | -$90.79 M(-11.4%) |
Sept 2016 | - | -$22.95 M(-22.9%) | -$102.52 M(-23.7%) |
June 2016 | - | -$29.76 M(+25.1%) | -$134.38 M(-21.7%) |
Mar 2016 | - | -$23.80 M(-8.5%) | -$171.59 M(-44.4%) |
Dec 2015 | -$308.41 M(+283.5%) | -$26.01 M(-52.5%) | -$308.41 M(-3.0%) |
Sept 2015 | - | -$54.81 M(-18.2%) | -$318.01 M(+10.9%) |
June 2015 | - | -$66.97 M(-58.3%) | -$286.65 M(+25.5%) |
Mar 2015 | - | -$160.62 M(+351.0%) | -$228.40 M(+184.0%) |
Dec 2014 | -$80.41 M(-6.6%) | -$35.62 M(+51.9%) | -$80.41 M(+30.2%) |
Sept 2014 | - | -$23.45 M(+169.2%) | -$61.77 M(-3.6%) |
June 2014 | - | -$8.71 M(-31.0%) | -$64.06 M(-21.3%) |
Mar 2014 | - | -$12.63 M(-25.6%) | -$81.40 M(-5.4%) |
Dec 2013 | -$86.06 M(+48.0%) | -$16.98 M(-34.1%) | -$86.06 M(-0.1%) |
Sept 2013 | - | -$25.74 M(-1.2%) | -$86.13 M(+8.6%) |
June 2013 | - | -$26.05 M(+50.7%) | -$79.31 M(+16.5%) |
Mar 2013 | - | -$17.29 M(+1.4%) | -$68.08 M(+17.1%) |
Dec 2012 | -$58.13 M(-38.3%) | -$17.05 M(-9.9%) | -$58.13 M(-39.4%) |
Sept 2012 | - | -$18.93 M(+27.8%) | -$95.99 M(+2.8%) |
June 2012 | - | -$14.81 M(+101.7%) | -$93.41 M(-1.7%) |
Mar 2012 | - | -$7.34 M(-86.6%) | -$95.06 M(+0.9%) |
Dec 2011 | -$94.21 M(+118.1%) | -$54.91 M(+235.8%) | -$94.21 M(+75.5%) |
Sept 2011 | - | -$16.35 M(-0.7%) | -$53.69 M(+10.4%) |
June 2011 | - | -$16.46 M(+153.5%) | -$48.63 M(+18.3%) |
Mar 2011 | - | -$6.49 M(-54.9%) | -$41.09 M(-4.9%) |
Dec 2010 | -$43.19 M(-19.5%) | -$14.39 M(+27.5%) | -$43.19 M(+0.9%) |
Sept 2010 | - | -$11.29 M(+26.4%) | -$42.82 M(-18.0%) |
June 2010 | - | -$8.93 M(+3.9%) | -$52.23 M(-5.6%) |
Mar 2010 | - | -$8.59 M(-38.7%) | -$55.33 M(+3.2%) |
Dec 2009 | -$53.62 M(-41.5%) | -$14.01 M(-32.3%) | -$53.62 M(-5.9%) |
Sept 2009 | - | -$20.70 M(+72.1%) | -$57.01 M(-3.4%) |
June 2009 | - | -$12.03 M(+74.9%) | -$58.99 M(-19.9%) |
Mar 2009 | - | -$6.88 M(-60.5%) | -$73.67 M(-19.6%) |
Dec 2008 | -$91.59 M | -$17.40 M(-23.3%) | -$91.59 M(-8.5%) |
Sept 2008 | - | -$22.68 M(-15.0%) | -$100.12 M(+5.0%) |
June 2008 | - | -$26.70 M(+7.6%) | -$95.37 M(+6.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | - | -$24.81 M(-4.3%) | -$89.89 M(-25.8%) |
Dec 2007 | -$121.13 M(+197.6%) | -$25.93 M(+44.6%) | -$121.13 M(+6.1%) |
Sept 2007 | - | -$17.93 M(-15.5%) | -$114.18 M(-6.5%) |
June 2007 | - | -$21.23 M(-62.1%) | -$122.08 M(+26.2%) |
Mar 2007 | - | -$56.04 M(+195.3%) | -$96.72 M(+137.6%) |
Dec 2006 | -$40.70 M(-423.2%) | -$18.98 M(-26.5%) | -$40.70 M(+91.1%) |
Sept 2006 | - | -$25.84 M(-724.6%) | -$21.30 M(-482.6%) |
June 2006 | - | $4.14 M(<-9900.0%) | $5.57 M(-140.8%) |
Mar 2006 | - | -$21.00 K(-105.0%) | -$13.65 M(-208.4%) |
Dec 2005 | $12.59 M(-134.3%) | $418.00 K(-59.6%) | $12.59 M(-154.8%) |
Sept 2005 | - | $1.03 M(-106.9%) | -$23.00 M(-4320.6%) |
June 2005 | - | -$15.08 M(-157.5%) | $545.00 K(-35.0%) |
Mar 2005 | - | $26.22 M(-174.5%) | $838.00 K(-102.3%) |
Dec 2004 | -$36.75 M(-58.1%) | -$35.18 M(-243.1%) | -$36.75 M(-36.7%) |
Sept 2004 | - | $24.58 M(-266.2%) | -$58.02 M(-37.9%) |
June 2004 | - | -$14.79 M(+30.1%) | -$93.48 M(-0.3%) |
Mar 2004 | - | -$11.37 M(-79.9%) | -$93.77 M(+6.9%) |
Dec 2003 | -$87.73 M(+87.6%) | -$56.45 M(+419.2%) | -$87.73 M(+68.6%) |
Sept 2003 | - | -$10.87 M(-27.9%) | -$52.04 M(+13.0%) |
June 2003 | - | -$15.08 M(+183.0%) | -$46.04 M(+14.4%) |
Mar 2003 | - | -$5.33 M(-74.3%) | -$40.24 M(-14.0%) |
Dec 2002 | -$46.77 M(+78.3%) | -$20.76 M(+326.4%) | -$46.77 M(-1.2%) |
Sept 2002 | - | -$4.87 M(-47.5%) | -$47.34 M(+3.4%) |
June 2002 | - | -$9.28 M(-21.7%) | -$45.81 M(-0.2%) |
Mar 2002 | - | -$11.86 M(-44.4%) | -$45.89 M(+75.0%) |
Dec 2001 | -$26.23 M(-208.3%) | -$21.33 M(+540.4%) | -$26.23 M(-331.9%) |
Sept 2001 | - | -$3.33 M(-64.4%) | $11.31 M(-9.5%) |
June 2001 | - | -$9.37 M(-220.1%) | $12.49 M(-28.7%) |
Mar 2001 | - | $7.80 M(-51.9%) | $17.53 M(-27.6%) |
Dec 2000 | $24.23 M(-162.1%) | $16.21 M(-854.2%) | $24.23 M(+83.3%) |
Sept 2000 | - | -$2.15 M(-50.4%) | $13.22 M(<-9900.0%) |
June 2000 | - | -$4.33 M(-129.9%) | -$134.00 K(-98.0%) |
Mar 2000 | - | $14.50 M(+178.8%) | -$6.60 M(-83.1%) |
Dec 1999 | -$39.00 M(-19.4%) | $5.20 M(-133.5%) | -$39.00 M(-52.1%) |
Sept 1999 | - | -$15.50 M(+43.5%) | -$81.50 M(+14.0%) |
June 1999 | - | -$10.80 M(-39.7%) | -$71.50 M(+17.0%) |
Mar 1999 | - | -$17.90 M(-52.0%) | -$61.10 M(+26.2%) |
Dec 1998 | -$48.40 M(+48.0%) | -$37.30 M(+578.2%) | -$48.40 M(+250.7%) |
Sept 1998 | - | -$5.50 M(+1275.0%) | -$13.80 M(-38.7%) |
June 1998 | - | -$400.00 K(-92.3%) | -$22.50 M(-7.0%) |
Mar 1998 | - | -$5.20 M(+92.6%) | -$24.20 M(-26.0%) |
Dec 1997 | -$32.70 M(-15.1%) | -$2.70 M(-81.0%) | -$32.70 M(-8.9%) |
Sept 1997 | - | -$14.20 M(+576.2%) | -$35.90 M(-1.4%) |
June 1997 | - | -$2.10 M(-84.7%) | -$36.40 M(-0.3%) |
Mar 1997 | - | -$13.70 M(+132.2%) | -$36.50 M(-5.2%) |
Dec 1996 | -$38.50 M(-9.0%) | -$5.90 M(-59.9%) | -$38.50 M(-42.1%) |
Sept 1996 | - | -$14.70 M(+568.2%) | -$66.50 M(+17.5%) |
June 1996 | - | -$2.20 M(-86.0%) | -$56.60 M(-6.0%) |
Mar 1996 | - | -$15.70 M(-53.7%) | -$60.20 M(+42.3%) |
Dec 1995 | -$42.30 M(+271.1%) | -$33.90 M(+606.3%) | -$42.30 M(+456.6%) |
Sept 1995 | - | -$4.80 M(-17.2%) | -$7.60 M(-14.6%) |
June 1995 | - | -$5.80 M(-363.6%) | -$8.90 M(-6.3%) |
Mar 1995 | - | $2.20 M(+175.0%) | -$9.50 M(-16.7%) |
Dec 1994 | -$11.40 M(+29.5%) | $800.00 K(-113.1%) | -$11.40 M(-34.5%) |
Sept 1994 | - | -$6.10 M(-4.7%) | -$17.40 M(+34.9%) |
June 1994 | - | -$6.40 M(-2233.3%) | -$12.90 M(+65.4%) |
Mar 1994 | - | $300.00 K(-105.8%) | -$7.80 M(-11.4%) |
Dec 1993 | -$8.80 M(-57.9%) | -$5.20 M(+225.0%) | -$8.80 M(+2833.3%) |
Sept 1993 | - | -$1.60 M(+23.1%) | -$300.00 K(-112.5%) |
June 1993 | - | -$1.30 M(+85.7%) | $2.40 M(-116.4%) |
Mar 1993 | - | -$700.00 K(-121.2%) | -$14.60 M(-30.1%) |
Dec 1992 | -$20.90 M(+29.8%) | $3.30 M(+200.0%) | -$20.90 M(-13.6%) |
Sept 1992 | - | $1.10 M(-106.0%) | -$24.20 M(-4.3%) |
June 1992 | - | -$18.30 M(+161.4%) | -$25.30 M(+261.4%) |
Mar 1992 | - | -$7.00 M | -$7.00 M |
Dec 1991 | -$16.10 M | - | - |
FAQ
- What is IDEXX Laboratories annual cash flow from investing activities?
- What is the all time high annual CFI for IDEXX Laboratories?
- What is IDEXX Laboratories annual CFI year-on-year change?
- What is IDEXX Laboratories quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly CFI year-on-year change?
- What is IDEXX Laboratories TTM cash flow from investing activities?
- What is the all time high TTM CFI for IDEXX Laboratories?
- What is IDEXX Laboratories TTM CFI year-on-year change?
What is IDEXX Laboratories annual cash flow from investing activities?
The current annual CFI of IDXX is -$125.25 M
What is the all time high annual CFI for IDEXX Laboratories?
IDEXX Laboratories all-time high annual cash flow from investing activities is $138.60 M
What is IDEXX Laboratories annual CFI year-on-year change?
Over the past year, IDXX annual cash flow from investing activities has changed by +$70.10 M (+35.88%)
What is IDEXX Laboratories quarterly cash flow from investing activities?
The current quarterly CFI of IDXX is -$27.37 M
What is the all time high quarterly CFI for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly cash flow from investing activities is $260.31 M
What is IDEXX Laboratories quarterly CFI year-on-year change?
Over the past year, IDXX quarterly cash flow from investing activities has changed by +$470.00 K (+1.69%)
What is IDEXX Laboratories TTM cash flow from investing activities?
The current TTM CFI of IDXX is -$197.65 M
What is the all time high TTM CFI for IDEXX Laboratories?
IDEXX Laboratories all-time high TTM cash flow from investing activities is $166.69 M
What is IDEXX Laboratories TTM CFI year-on-year change?
Over the past year, IDXX TTM cash flow from investing activities has changed by -$53.61 M (-37.21%)